Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions
Diabetes & Metabolism Journal · 01.09.2025 · 49 (5) · 934-950
DOI: 10.4093/dmj.2025.0561 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 01.09.2025. Verfasst von Matthew J Savage und 6 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Centre, University of Leicester, Leicester, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute for Health and Care Research, NIHR Leicester Biomedical Research Centre, Applied Research Collaboration East Midlands.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The global prevalence of early-onset type 2 diabetes (EOT2D) is rising rapidly. Adults with EOT2D represent a high-risk population characterised by increased rates of microvascular and macrovascular complications, adverse psychological wellbeing and psychiatric comorbidities such as depression, and premature mortality compared to those with later-onset type 2 diabetes mellitus. This emerging population faces unique challenges, including high levels of diabetes-related stigma, clinical inertia, and competing life demands, such as starting a family. This review synthesises current evidence on the clinical management of EOT2D. Key therapeutic targets include weight reduction, preservation of β-cell function, cardiometabolic risk management, and psychological support. Overall, there are few randomized controlled trials (RCTs) undertaken specifically in adults with EOT2D. However, we summarise early data from the few RCTs that do report outcomes specific in young adults, with bariatric surgery, tirzepatide and intensive lifestyle interventions emerging as particularly effective treatments. There is a strong rationale that technology-based inventions and structured education programs may prove to be effective treatments but data from RCTs is lacking. We provide broad recommendations for future research and clinical practice based on the current evidence. In conclusion, substantial further research is required to inform tailored, evidence-based guidelines and improve long-term outcomes in this underserved population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes Research Centre, University of Leicester, Leicester, UK.
- NIHR Leicester Biomedical Research Centre, Leicester, UK.
- Department of Diabetes and Endocrinology, University Hospitals of Derby and Burton NHS Foundation Trust, Royal Derby Hospital, Derby, UK.
- School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Förderung
- National Institute for Health and Care Research
- NIHR Leicester Biomedical Research Centre
- Applied Research Collaboration East Midlands
- Welcome Trust Leicestershire Healthcare Inequalities Improvement Doctoral Training Programme
Zitieren
APA
Savage, M. J., Goldney, J., Slater, T., Sarkar, P., Sargeant, J. A., Wilmot, E. G., & Davies, M. J. (2025). Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions. Diabetes & Metabolism Journal, 49(5), 934-950. https://doi.org/10.4093/dmj.2025.0561
Vancouver
Savage MJ, Goldney J, Slater T, Sarkar P, Sargeant JA, Wilmot EG, et al. Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions. Diabetes & Metabolism Journal. 2025;49(5):934-950. doi:10.4093/dmj.2025.0561
BibTeX
@article{Savage2025,
author = {Savage, Matthew J and Goldney, Jonathan and Slater, Tommy and Sarkar, Priscilla and Sargeant, Jack A and Wilmot, Emma G and Davies, Melanie J},
title = {Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions},
journal = {Diabetes & Metabolism Journal},
year = {2025},
volume = {49},
number = {5},
pages = {934--950},
doi = {10.4093/dmj.2025.0561}
}
EUVIMED